Plethysmographic patterns in scleroderma after percutaneous G.A.G. treatment.
D000287:Administration, Topical; D000328:Adult; D006025:Glycosaminoglycans / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D010991:Plethysmography; D011928:Raynaud Disease / Q000209:etiology; D012595:Scleroderma, Systemic / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology
D006025:Glycosaminoglycans